|
gptkbp:instanceOf
|
gptkb:antibiotic
gptkb:drug
|
|
gptkbp:activeIngredient
|
gptkb:ertapenem
|
|
gptkbp:approvalYear
|
2001
|
|
gptkbp:approvedBy
|
gptkb:United_States
|
|
gptkbp:ATCCode
|
gptkb:J01DH03
|
|
gptkbp:CASNumber
|
gptkb:153832-46-3
|
|
gptkbp:chemicalFormula
|
gptkb:C22H25N3O7S
|
|
gptkbp:contraindication
|
hypersensitivity to carbapenems
|
|
gptkbp:drugClass
|
carbapenem antibiotic
|
|
gptkbp:eliminationHalfLife
|
4 hours
|
|
gptkbp:excretion
|
renal
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Invanz
|
|
gptkbp:indication
|
complicated urinary tract infections
prophylaxis of surgical site infection in colorectal surgery
acute pelvic infections
community-acquired pneumonia
complicated intra-abdominal infections
complicated skin and skin structure infections
|
|
gptkbp:KEGGID
|
gptkb:D07917
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Merck_&_Co.
|
|
gptkbp:MedlinePlusID
|
a603026
|
|
gptkbp:pregnancyCategory
|
B
B1
|
|
gptkbp:prescriptionStatus
|
Rx-only
|
|
gptkbp:proteinBinding
|
85-95%
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL1092
gptkb:DB00303
149596
|
|
gptkbp:routeOfAdministration
|
intramuscular
intravenous
|
|
gptkbp:sideEffect
|
nausea
diarrhea
headache
phlebitis
seizures
rash
|
|
gptkbp:spectrumOfActivity
|
broad-spectrum
|
|
gptkbp:UNII
|
82ZCD1D34N
|
|
gptkbp:usedFor
|
bacterial infections
|
|
gptkbp:bfsParent
|
gptkb:Merck_&_Co.
|
|
gptkbp:bfsLayer
|
4
|